Showing 6 results
Archival DescriptionModelling disease progression & treatment effects in multiple sclerosis within a cost-effectiveness study / Murray G. Brown & Chris Skedgel
Modelling disease progression & treatment effects in multiple sclerosis within a cost-effectiveness study / Murray G. Brown & Chris Skedgel
Conference schedule for MS research presentations
Conference schedule for MS research presentations
Multiple sclerosis disease-modifying drug and health care costs in Nova Scotia, 1989 -2003 / Vern Hicks, Murray G. Brown, I.S. Sketris
Multiple sclerosis disease-modifying drug and health care costs in Nova Scotia, 1989 -2003 / Vern Hicks, Murray G. Brown, I.S. Sketris
How effective are new drugs in delaying disability progression in relapsing remitting onset multiple sclerosis? A subgroup analysis
How effective are new drugs in delaying disability progression in relapsing remitting onset multiple sclerosis? A subgroup analysis
Modelling health outcomes in relapsing-remitting-onset multiple sclerosis cohorts treated with disease-modifying drugs that delay disability progression
Modelling health outcomes in relapsing-remitting-onset multiple sclerosis cohorts treated with disease-modifying drugs that delay disability progression
Information sinkholes on the road to representative estimates of MS disability progression speed ....
Information sinkholes on the road to representative estimates of MS disability progression speed ....